These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13248731)

  • 41. [Triethylene melamine in combination with radiotherapy].
    SARASIN R; DUBOIS-FERRIERE H
    J Belge Radiol; 1951; 34(4):489-93. PubMed ID: 14946150
    [No Abstract]   [Full Text] [Related]  

  • 42. [Triethylene melamine in Hodgkin's disease].
    HOST H; QVIGSTAD G
    Nord Med; 1955 Sep; 54(36):1383-5. PubMed ID: 13266133
    [No Abstract]   [Full Text] [Related]  

  • 43. Triethylene melamine in bronchogenic carcinoma with vena caval obstruction.
    SALINE M; BAUM GL
    J Am Med Assoc; 1954 Dec; 156(16):1493-5. PubMed ID: 13211274
    [No Abstract]   [Full Text] [Related]  

  • 44. Primary carcinoma of the liver: report of 20 cases, including two treated with triethylene melamine.
    WILSON HM
    Ann Intern Med; 1954 Jul; 41(1):118-23. PubMed ID: 13171795
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of triethylene melamine in treatment of leukemia and leukosarcoma.
    SILVERBERG JH; DAMESHEK W
    J Am Med Assoc; 1952 Mar; 148(12):1015-21. PubMed ID: 14897704
    [No Abstract]   [Full Text] [Related]  

  • 46. Some clinical experience in the use of triethylene melamine (TEM).
    HAMERMAN DJ; MELAMED S
    J Mt Sinai Hosp N Y; 1953; 20(1):16-26. PubMed ID: 13061942
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical use of triethylene melamine; report of seventy-five cases.
    BOND WH; ROHN RJ; DYKE RW; FOUTS PJ
    AMA Arch Intern Med; 1953 May; 91(5):602-17. PubMed ID: 13039612
    [No Abstract]   [Full Text] [Related]  

  • 48. Triethylene melamine in the treatment of lymphomas and leukemias.
    KARNOFSKY DA
    Med Clin North Am; 1954 Mar; 11():541-54. PubMed ID: 13153527
    [No Abstract]   [Full Text] [Related]  

  • 49. Action of tri-ethylene melamine in mice.
    KRAUS SD; WEINTRAUB S; WRIGHT LT
    Proc Soc Exp Biol Med; 1951 Mar; 76(3):489-93. PubMed ID: 14844250
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of polycythemia vera with triethylene melamine; summary of thirty cases.
    ROSENTHAL N; ROSENTHAL RL
    AMA Arch Intern Med; 1952 Sep; 90(3):379-88. PubMed ID: 14952061
    [No Abstract]   [Full Text] [Related]  

  • 51. [Thirty cases of chronic leukemic lymphadenosis treated with intravenous administration of triethylene melamine].
    GIGANTE D; ZOPPINI A
    Prog Med (Napoli); 1956 Jun; 12(12):361-8. PubMed ID: 13350408
    [No Abstract]   [Full Text] [Related]  

  • 52. [Triethylene melanine in the treatment of certain blood diseases].
    PAVLOVSKY A; VILASECA GC
    Sang; 1953; 24(7):578-91. PubMed ID: 13135374
    [No Abstract]   [Full Text] [Related]  

  • 53. The immediate action of triethylene melamine in chronic lymphatic leuchaemia.
    BOLTON JH; BEAN RH
    Med J Aust; 1954 Sep; 2(12):474-8. PubMed ID: 13213377
    [No Abstract]   [Full Text] [Related]  

  • 54. [Triethylenemelamine (TEM) in lymphatic leukemia].
    PRIBILLA W; STOLLBERG G
    Munch Med Wochenschr; 1954 Oct; 96(41):1189-91. PubMed ID: 13223716
    [No Abstract]   [Full Text] [Related]  

  • 55. Triethylenemelamine in polycythemia vera; a therapeutic trial.
    ELLISON RR; GINSBERG V; WATSON J
    Cancer; 1953 Mar; 6(2):327-32. PubMed ID: 13032924
    [No Abstract]   [Full Text] [Related]  

  • 56. Triethylene melamine (TEM) therapy in malignant diseases.
    RUNDLES RW
    GP; 1954 May; 9(5):75-80. PubMed ID: 13151309
    [No Abstract]   [Full Text] [Related]  

  • 57. [Triethylenemelanine in the treatment of lymphogranulomatoses and hemoblastoses].
    WINKLER A; CERNY V
    Cesk Onkol; 1954; 1(1):30-8. PubMed ID: 14390616
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparative actions of 2, 4, 6-triethyleneimino 1, 3, 5-triazine and of 2, 5-bis-ethylene-imino-hydroquinone on mitosis in segmentation of Pleurodeles eggs].
    SENTEIN P
    C R Seances Soc Biol Fil; 1956 Sep; 150(4):762-4. PubMed ID: 13365204
    [No Abstract]   [Full Text] [Related]  

  • 59. EVIDENCE OF AN ESSENTIAL DIFFERENCE BETWEEN THE GENETICAL EFFECTS OF MONO- AND BI-FUNCTIONAL ALKYLATING AGENTS.
    WATSON WA
    Z Vererbungsl; 1964 Dec; 95():374-8. PubMed ID: 14315528
    [No Abstract]   [Full Text] [Related]  

  • 60. [Additional occurrence of carcinoma in a malignant disease treated with triethylene melamine].
    LUHRS W; SCHAMMEL J; LOTZ HH
    Z Gesamte Inn Med; 1954 Mar; 9(6):295-9. PubMed ID: 13170253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.